{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T09:24:53Z","timestamp":1790846693796,"version":"4.1.0"},"reference-count":90,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.schres.2022.09.014","type":"journal-article","created":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T19:49:50Z","timestamp":1663876190000},"page":"331-340","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Relapse of first-episode schizophrenia patients and neurocognitive impairment: The role of dopaminergic and anticholinergic burden"],"prefix":"10.1016","volume":"248","author":[{"given":"Manuel J.","family":"Cuesta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Ballesteros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana M.","family":"S\u00e1nchez-Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Amoretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose M.","family":"L\u00f3pez-Ilundain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Merch\u00e1n-Naranjo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itxaso","family":"Gonz\u00e1lez-Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Purificaci\u00f3n","family":"Salgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Rodriguez-Jimenez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Rold\u00e1n-Bejarano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvador","family":"Sarr\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngela","family":"Ib\u00e1\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Usall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00aa. Jos\u00e9","family":"Escart\u00ed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc\u00eda","family":"Moreno-Izco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gisela","family":"Mezquida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mara","family":"Parellada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Gonz\u00e1lez-Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Berrocoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Bernardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2022.09.014_bb0005","series-title":"A Gentle Introduction to Stata","author":"Acock","year":"2014"},{"issue":"1","key":"10.1016\/j.schres.2022.09.014_bb0010","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.schres.2012.05.007","article-title":"Risk factors for relapse following treatment for first episode psychosis: a systematic review and meta-analysis of longitudinal studies","volume":"139","author":"Alvarez-Jimenez","year":"2012","journal-title":"Schizophr. Res."},{"issue":"3","key":"10.1016\/j.schres.2022.09.014_bb0015","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1176\/appi.ajp.162.3.441","article-title":"Remission in schizophrenia: proposed criteria and rationale for consensus","volume":"162","author":"Andreasen","year":"2005","journal-title":"Am. J. Psychiatry"},{"issue":"6","key":"10.1016\/j.schres.2022.09.014_bb0020","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1097\/JCP.0000000000000790","article-title":"The impact of medication anticholinergic burden on cognitive performance in people with schizophrenia","volume":"37","author":"Ang","year":"2017","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2022.09.014_bb1000","series-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)","year":"1994"},{"key":"10.1016\/j.schres.2022.09.014_bb0025","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.pnpbp.2012.11.012","article-title":"Predictors of neurocognitive impairment at 3 years after a first episode non-affective psychosis","volume":"43","author":"Ayesa-Arriola","year":"2013","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2022.09.014_bb0030","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.psychres.2013.01.024","article-title":"The relevance of cognitive, clinical and premorbid variables in predicting functional outcome for individuals with first-episode psychosis: a 3 year longitudinal study","volume":"209","author":"Ayesa-Arriola","year":"2013","journal-title":"Psychiatry Res."},{"issue":"13","key":"10.1016\/j.schres.2022.09.014_bb0035","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1017\/S0033291717003774","article-title":"Is cognitive impairment associated with antipsychotic dose and anticholinergic equivalent loads in first-episode psychosis?","volume":"48","author":"Ballesteros","year":"2018","journal-title":"Psychol. Med."},{"key":"10.1016\/j.schres.2022.09.014_bb0040","first-page":"1","article-title":"The longitudinal effect of antipsychotic burden on psychosocial functioning in first-episode psychosis patients: the role of verbal memory","author":"Ballesteros","year":"2020","journal-title":"Psychol. Med."},{"key":"10.1016\/j.schres.2022.09.014_bb0045","doi-asserted-by":"crossref","first-page":"643","DOI":"10.3389\/fnhum.2013.00643","article-title":"Ten year neurocognitive trajectories in first-episode psychosis","volume":"7","author":"Barder","year":"2013","journal-title":"Front. Hum. Neurosci."},{"issue":"4558","key":"10.1016\/j.schres.2022.09.014_bb0050","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1126\/science.7046051","article-title":"The cholinergic hypothesis of geriatric memory dysfunction","volume":"217","author":"Bartus","year":"1982","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.schres.2022.09.014_bb0055","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1093\/schbul\/sbt065","article-title":"Life events and psychosis: a review and meta-analysis","volume":"39","author":"Beards","year":"2013","journal-title":"Schizophr. Bull."},{"issue":"3","key":"10.1016\/j.schres.2022.09.014_bb0060","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.rpsm.2020.07.004","article-title":"The prevention of relapses in first episodes of schizophrenia: the 2EPs project, background, rationale and study design","volume":"14","author":"Bernardo","year":"2021","journal-title":"Rev. Psiquiatr. Salud Ment."},{"key":"10.1016\/j.schres.2022.09.014_bb0065","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.schres.2020.09.016","article-title":"Individualized prediction of 2-year risk of relapse as indexed by psychiatric hospitalization following psychosis onset: model development in two first episode samples","volume":"228","author":"Bhattacharyya","year":"2021","journal-title":"Schizophr. Res."},{"issue":"33","key":"10.1016\/j.schres.2022.09.014_bb0070","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1192\/S0007125000297663","article-title":"Early intervention in psychosis. The critical period hypothesis","volume":"172","author":"Birchwood","year":"1998","journal-title":"Br. J. Psychiatry Suppl."},{"key":"10.1016\/j.schres.2022.09.014_bb0075","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.schres.2017.11.010","article-title":"Clinical and demographic predictors of continuing remission or relapse following discontinuation of antipsychotic medication after a first episode of psychosis.A systematic review","volume":"197","author":"Bowtell","year":"2018","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.schres.2022.09.014_bb0080","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3109\/00048674.2010.541418","article-title":"Longitudinal studies of cognition in first episode psychosis: a systematic review of the literature","volume":"45","author":"Bozikas","year":"2011","journal-title":"Aust. N. Z. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2022.09.014_bb0085","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1017\/S0033291703008900","article-title":"Medications and verbal memory impairment in schizophrenia: the role of anticholinergic drugs","volume":"34","author":"Br\u00e9bion","year":"2004","journal-title":"Psychol. Med."},{"issue":"1","key":"10.1016\/j.schres.2022.09.014_bb0090","doi-asserted-by":"crossref","DOI":"10.1093\/schizbullopen\/sgaa017","article-title":"Rates and predictors of relapse in first-episode psychosis: an Australian cohort study","volume":"1","author":"Brown","year":"2020","journal-title":"Schizophr. Bull. Open"},{"issue":"1","key":"10.1016\/j.schres.2022.09.014_bb0095","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/schbul\/sbi020","article-title":"A summary of the FDA-NIMH-MATRICS workshop on clinical trial design for neurocognitive drugs for schizophrenia","volume":"31","author":"Buchanan","year":"2005","journal-title":"Schizophr. Bull."},{"issue":"3","key":"10.1016\/j.schres.2022.09.014_bb0100","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1093\/schbul\/sby115","article-title":"Early-stage negative symptom trajectories and relationships with 13-year outcomes in first-episode nonaffective psychosis","volume":"45","author":"Chang","year":"2019","journal-title":"Schizophr. Bull."},{"issue":"1","key":"10.1016\/j.schres.2022.09.014_bb0105","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.schres.2005.02.020","article-title":"A prospective 3-year longitudinal study of cognitive predictors of relapse in first-episode schizophrenic patients","volume":"77","author":"Chen","year":"2005","journal-title":"Schizophr. Res."},{"issue":"12","key":"10.1016\/j.schres.2022.09.014_bb0110","doi-asserted-by":"crossref","first-page":"e113","DOI":"10.1016\/j.biopsych.2011.03.028","article-title":"Inverted-U-shaped dopamine actions on human working memory and cognitive control","volume":"69","author":"Cools","year":"2011","journal-title":"Biol. Psychiatry"},{"issue":"5","key":"10.1016\/j.schres.2022.09.014_bb0115","doi-asserted-by":"crossref","first-page":"717","DOI":"10.4088\/JCP.08m04634","article-title":"Neurocognitive effectiveness of haloperidol, risperidone, and olanzapine in first-episode psychosis: a randomized, controlled 1-year follow-up comparison","volume":"70","author":"Crespo-Facorro","year":"2009","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2022.09.014_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2020.113404","article-title":"Validity and utility of a set of clinical criteria for cognitive impairment associated with psychosis (CIAPs)","volume":"293","author":"Cuesta","year":"2020","journal-title":"Psychiatry Res."},{"issue":"3","key":"10.1016\/j.schres.2022.09.014_bb0125","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1176\/appi.ajp.162.3.627","article-title":"Benztropine equivalents for antimuscarinic medication","volume":"162","author":"de Leon","year":"2005","journal-title":"Am. J. Psychiatry"},{"issue":"6","key":"10.1016\/j.schres.2022.09.014_bb0130","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1177\/2045125314553611","article-title":"Effects of discontinuing anticholinergic treatment on movement disorders, cognition and psychopathology in patients with schizophrenia","volume":"4","author":"Desmarais","year":"2014","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"10.1016\/j.schres.2022.09.014_bb0135","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.schres.2017.03.034","article-title":"Cognitive burden of anticholinergic medications in psychotic disorders","volume":"190","author":"Eum","year":"2017","journal-title":"Schizophr. Res."},{"issue":"3","key":"10.1016\/j.schres.2022.09.014_bb0140","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.neubiorev.2010.07.001","article-title":"The relationship between neurocognition and social cognition with functional outcomes in schizophrenia: a meta-analysis","volume":"35","author":"Fett","year":"2011","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"6","key":"10.1016\/j.schres.2022.09.014_bb0145","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1176\/appi.ajp.2009.09060802","article-title":"International consensus study of antipsychotic dosing","volume":"167","author":"Gardner","year":"2010","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2022.09.014_bb0150","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.779607","article-title":"Anticholinergic burden and cognitive performance in patients with schizophrenia: a systematic literature review","volume":"12","author":"Georgiou","year":"2021","journal-title":"Front. Psychiatry"},{"issue":"10","key":"10.1016\/j.schres.2022.09.014_bb0155","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1001\/archpsyc.64.10.1115","article-title":"Cognitive improvement after treatment with second-generation antipsychotic medications in first-episode schizophrenia: is it a practice effect?","volume":"64","author":"Goldberg","year":"2007","journal-title":"Arch. Gen. Psychiatry"},{"issue":"5","key":"10.1016\/j.schres.2022.09.014_bb0160","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/npp.2009.211","article-title":"Circumstances under which practice does not make perfect: a review of the practice effect literature in schizophrenia and its relevance to clinical treatment studies","volume":"35","author":"Goldberg","year":"2010","journal-title":"Neuropsychopharmacology"},{"issue":"16","key":"10.1016\/j.schres.2022.09.014_bb0165","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1017\/S0033291719002794","article-title":"Influence of social cognition as a mediator between cognitive reserve and psychosocial functioning in patients with first episode psychosis","volume":"50","author":"Gonz\u00e1lez-Ortega","year":"2020","journal-title":"Psychol. Med."},{"key":"10.1016\/j.schres.2022.09.014_bb0170","doi-asserted-by":"crossref","first-page":"570","DOI":"10.3389\/fphar.2020.00570","article-title":"The prognostic value of anticholinergic burden measures in relation to mortality in older individuals: a systematic review and meta-analysis","volume":"11","author":"Graves-Morris","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.schres.2022.09.014_bb0175","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/schbul\/sbn045","article-title":"Social cognition in schizophrenia","volume":"34","author":"Green","year":"2008","journal-title":"Schizophr. Bull."},{"issue":"4","key":"10.1016\/j.schres.2022.09.014_bb0180","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1093\/schbul\/sbq171","article-title":"Social cognition in schizophrenia, part 1: performance across phase of illness","volume":"38","author":"Green","year":"2012","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2022.09.014_bb0185","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1192\/bjp.178.6.506","article-title":"Recovery from psychotic illness: a 15- and 25-year international follow-up study","volume":"178","author":"Harrison","year":"2001","journal-title":"Br. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2022.09.014_bb0190","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/arclin\/16.1.75","article-title":"Detecting change: a comparison of three neuropsychological methods, using normal and clinical samples","volume":"16","author":"Heaton","year":"2001","journal-title":"Arch. Clin. Neuropsychol."},{"issue":"8","key":"10.1016\/j.schres.2022.09.014_bb0195","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1001\/archinte.167.8.781","article-title":"A drug burden index to define the functional burden of medications in older people","volume":"167","author":"Hilmer","year":"2007","journal-title":"Arch. Intern. Med."},{"issue":"1","key":"10.1016\/j.schres.2022.09.014_bb0200","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.schres.2005.05.010","article-title":"Ten year longitudinal study of neuropsychological functioning subsequent to a first episode of schizophrenia","volume":"78","author":"Hoff","year":"2005","journal-title":"Schizophr. Res."},{"issue":"1\u20133","key":"10.1016\/j.schres.2022.09.014_bb0205","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.psychres.2005.07.037","article-title":"Predictive value of cognition for different domains of outcome in recent-onset schizophrenia","volume":"149","author":"Holthausen","year":"2007","journal-title":"Psychiatry Res."},{"issue":"3","key":"10.1016\/j.schres.2022.09.014_bb0210","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1093\/schbul\/sbp006","article-title":"The dopamine hypothesis of schizophrenia: version III-the final common pathway","volume":"35","author":"Howes","year":"2009","journal-title":"Schizophr. Bull."},{"issue":"13","key":"10.1016\/j.schres.2022.09.014_bb0215","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1017\/S0033291718003070","article-title":"Predicting first-episode psychosis patients who will never relapse over 10 years","volume":"49","author":"Hui","year":"2019","journal-title":"Psychol. Med."},{"key":"10.1016\/j.schres.2022.09.014_bb0220","series-title":"IBM SPSS Statistics for Windows, Version 22.0","year":"2013"},{"issue":"1","key":"10.1016\/j.schres.2022.09.014_bb0225","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.biopsych.2018.07.003","article-title":"The effects of antipsychotic treatment on presynaptic dopamine synthesis capacity in first-episode psychosis: a positron emission tomography study","volume":"85","author":"Jauhar","year":"2019","journal-title":"Biol. Psychiatry"},{"issue":"9","key":"10.1016\/j.schres.2022.09.014_bb0230","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1176\/appi.ajp.2020.20081212","article-title":"Anticholinergic medication burden-associated cognitive impairment in schizophrenia","volume":"178","author":"Joshi","year":"2021","journal-title":"Am. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2022.09.014_bb0235","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1176\/appi.ajp.2015.15050632","article-title":"Comprehensive versus usual community care for first-episode psychosis: 2-year outcomes from the NIMH RAISE Early Treatment Program","volume":"173","author":"Kane","year":"2016","journal-title":"Am. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2022.09.014_bb0240","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"issue":"6","key":"10.1016\/j.schres.2022.09.014_bb0245","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1038\/sj.npp.1301499","article-title":"Efficacy and safety of donepezil in patients with schizophrenia or schizoaffective disorder: significant placebo\/practice effects in a 12-week, randomized, double-blind, placebo-controlled trial","volume":"33","author":"Keefe","year":"2008","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.schres.2022.09.014_bb0250","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/schbul\/sbaa093","article-title":"The impact of anticholinergic burden on functional capacity in persons with schizophrenia across the adult life span","volume":"47","author":"Khan","year":"2021","journal-title":"Schizophr. Bull."},{"issue":"3","key":"10.1016\/j.schres.2022.09.014_bb0255","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1755-5949.2010.00142.x","article-title":"Acetylcholine-dopamine interactions in the pathophysiology and treatment of CNS disorders","volume":"16","author":"Lester","year":"2010","journal-title":"CNS Neurosci. Ther."},{"issue":"Suppl. 1","key":"10.1016\/j.schres.2022.09.014_bb0260","doi-asserted-by":"crossref","first-page":"S90","DOI":"10.1093\/schbul\/sbv167","article-title":"Dose equivalents for antipsychotic drugs: the DDD method","volume":"42","author":"Leucht","year":"2016","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2022.09.014_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.archger.2019.05.010","article-title":"A review of published anticholinergic scales and measures and their applicability in database analyses","volume":"87","author":"Lozano-Ortega","year":"2020","journal-title":"Arch. Gerontol. Geriatr."},{"key":"10.1016\/j.schres.2022.09.014_bb0270","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.schres.2017.01.047","article-title":"The course of negative symptoms in first-episode schizophrenia and its predictors: a prospective two-year follow-up study","volume":"189","author":"Mezquida","year":"2017","journal-title":"Schizophr. Res."},{"issue":"1","key":"10.1016\/j.schres.2022.09.014_bb0275","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1176\/appi.ajp.161.1.116","article-title":"Association of anticholinergic load with impairment of complex attention and memory in schizophrenia","volume":"161","author":"Minzenberg","year":"2004","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2022.09.014_bb0280","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2022.09.014_bb0285","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1080\/13546805.2018.1440201","article-title":"Social cognition in the course of psychosis and its correlation with biomarkers in a male cohort","volume":"23","author":"Ntouros","year":"2018","journal-title":"Cogn. Neuropsychiatry"},{"key":"10.1016\/j.schres.2022.09.014_bb0290","series-title":"MCCB: Matrics Consensus Cognitive Battery","author":"Nuechterlein","year":"2006"},{"issue":"1","key":"10.1016\/j.schres.2022.09.014_bb0295","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1744-859X-12-32","article-title":"Definitions and drivers of relapse in patients with schizophrenia: a systematic literature review","volume":"12","author":"Olivares","year":"2013","journal-title":"Ann. Gen.Psychiatry"},{"issue":"13","key":"10.1016\/j.schres.2022.09.014_bb0300","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1017\/S0033291715000860","article-title":"Cognitive performance during the first year of treatment in first-episode schizophrenia: a case-control study","volume":"45","author":"Olivier","year":"2015","journal-title":"Psychol. Med."},{"issue":"2","key":"10.1016\/j.schres.2022.09.014_bb0305","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1192\/bjp.bp.113.127753","article-title":"Duration of untreated psychosis as predictor of long-term outcome in schizophrenia: systematic review and meta-analysis","volume":"205","author":"Penttil\u00e4","year":"2014","journal-title":"Br. J. Psychiatry"},{"issue":"8","key":"10.1016\/j.schres.2022.09.014_bb0310","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/0006-3223(94)90620-3","article-title":"Lack of insight: its status within schizophrenic psychopathology","volume":"36","author":"Peralta","year":"1994","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2022.09.014_bb0315","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0165-1781(94)90093-0","article-title":"Psychometric properties of the positive and negative syndrome scale (PANSS) in schizophrenia","volume":"53","author":"Peralta","year":"1994","journal-title":"Psychiatry Res."},{"issue":"1","key":"10.1016\/j.schres.2022.09.014_bb0320","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0920-9964(99)00161-9","article-title":"Characterizing and dating the onset of symptoms in psychotic illness: the Symptom Onset in Schizophrenia (SOS) inventory","volume":"44","author":"Perkins","year":"2000","journal-title":"Schizophr. Res."},{"issue":"8","key":"10.1016\/j.schres.2022.09.014_bb0325","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1017\/S0033291718002131","article-title":"Transdiagnostic dimensions of psychopathology at first episode psychosis: findings from the multinational EU-GEI study","volume":"49","author":"Quattrone","year":"2019","journal-title":"Psychol. Med."},{"issue":"3","key":"10.1016\/j.schres.2022.09.014_bb0330","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1001\/archpsyc.56.3.241","article-title":"Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder","volume":"56","author":"Robinson","year":"1999","journal-title":"Arch. Gen. Psychiatry"},{"issue":"7","key":"10.1016\/j.schres.2022.09.014_bb0335","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1176\/appi.ps.201800511","article-title":"Predictors of hospitalization of individuals with first-episode psychosis: data from a 2-year follow-up of the RAISE-ETP","volume":"70","author":"Robinson","year":"2019","journal-title":"Psychiatr. Serv."},{"issue":"1\u20133","key":"10.1016\/j.schres.2022.09.014_bb0340","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.schres.2006.11.030","article-title":"The course of neurocognitive functioning in first-episode psychosis and its relation to premorbid adjustment, duration of untreated psychosis, and relapse","volume":"91","author":"Rund","year":"2007","journal-title":"Schizophr. Res."},{"issue":"1","key":"10.1016\/j.schres.2022.09.014_bb0345","first-page":"87","article-title":"Neurocognition and duration of psychosis: a 10-year follow-up of first-episode patients","volume":"42","author":"Rund","year":"2016","journal-title":"Schizophr. Bull."},{"issue":"3","key":"10.1016\/j.schres.2022.09.014_bb0350","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1093\/schbul\/sbr189","article-title":"Dopamine D2 receptor occupancy and cognition in schizophrenia: analysis of the CATIE data","volume":"39","author":"Sakurai","year":"2012","journal-title":"Schizophr. Bull."},{"issue":"1","key":"10.1016\/j.schres.2022.09.014_bb0355","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10010073","article-title":"Exploring risk and resilient profiles for functional impairment and baseline predictors in a 2-year follow-up first-episode psychosis cohort using latent class growth analysis","volume":"10","author":"Salagre","year":"2020","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.schres.2022.09.014_bb0360","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1176\/appi.ps.201100084","article-title":"Predictors of relapse in the year after hospital discharge among patients with schizophrenia","volume":"63","author":"Schennach","year":"2012","journal-title":"Psychiatr. Serv."},{"issue":"1","key":"10.1016\/j.schres.2022.09.014_bb0365","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1017\/S0033291715001646","article-title":"The effects of cannabis on memory function in users with and without a psychotic disorder: findings from a combined meta-analysis","volume":"46","author":"Schoeler","year":"2016","journal-title":"Psychol. Med."},{"issue":"1","key":"10.1016\/j.schres.2022.09.014_bb0370","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1177\/0004867414560650","article-title":"The use of clinical and biological characteristics to predict outcome following First Episode Psychosis","volume":"49","author":"Schubert","year":"2015","journal-title":"Aust. N. Z. J. Psychiatry"},{"issue":"1\u20133","key":"10.1016\/j.schres.2022.09.014_bb0375","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.schres.2012.09.004","article-title":"Cognitive functioning in at-risk mental states for psychosis and 2-year clinical outcome","volume":"142","author":"Simon","year":"2012","journal-title":"Schizophr. Res."},{"issue":"2\u20133","key":"10.1016\/j.schres.2022.09.014_bb0380","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0920-9964(03)00014-8","article-title":"Neurocognitive function and outcome in first-episode schizophrenia: a 10-year follow-up of an epidemiological cohort","volume":"65","author":"Stirling","year":"2003","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2022.09.014_bb0385","doi-asserted-by":"crossref","first-page":"580","DOI":"10.3389\/fpsyt.2018.00580","article-title":"Is it possible to predict the future in first-episode psychosis?","volume":"9","author":"Suvisaari","year":"2018","journal-title":"Front.Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2022.09.014_bb0390","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0165-1781(91)90053-R","article-title":"Evaluation of the stability of neuropsychological functioning after acute episodes of schizophrenia: one-year followup study","volume":"38","author":"Sweeney","year":"1991","journal-title":"Psychiatry Res."},{"issue":"4","key":"10.1016\/j.schres.2022.09.014_bb0395","doi-asserted-by":"crossref","first-page":"e816","DOI":"10.1097\/PTS.0000000000000929","article-title":"Concordance among 10 different anticholinergic burden scales in at-risk older populations","volume":"18","author":"Tristancho-P\u00e9rez","year":"2022","journal-title":"J. Patient Saf."},{"issue":"9","key":"10.1016\/j.schres.2022.09.014_bb0400","doi-asserted-by":"crossref","first-page":"e1284","DOI":"10.4088\/JCP.17m11523","article-title":"Anticholinergic burden and cognition in older patients with schizophrenia","volume":"78","author":"Tsoutsoulas","year":"2017","journal-title":"J. Clin. Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2022.09.014_bb0405","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1034\/j.1600-0447.2000.102003203.x","article-title":"Medication adherence in psychosis: predictors and impact on outcome. A 2-year follow-up of first-admitted subjects","volume":"102","author":"Verdoux","year":"2000","journal-title":"Acta Psychiatr. Scand."},{"issue":"5","key":"10.1016\/j.schres.2022.09.014_bb0410","first-page":"647","article-title":"Development of the anticholinergic burden calculator web tool","volume":"41","author":"Villalba-Moreno","year":"2017","journal-title":"Farm. Hosp."},{"issue":"5","key":"10.1016\/j.schres.2022.09.014_bb0415","first-page":"170","article-title":"Comments on the anticholinergic burden calculator web tool.REPLY","volume":"43","author":"Villalba-Moreno","year":"2019","journal-title":"Farm. Hosp."},{"key":"10.1016\/j.schres.2022.09.014_bb0420","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.schres.2016.09.029","article-title":"Five-fold increased risk of relapse following breaks in antipsychotic treatment of first episode psychosis","volume":"179","author":"Winton-Brown","year":"2017","journal-title":"Schizophr. Res."},{"issue":"Suppl. 5","key":"10.1016\/j.schres.2022.09.014_bb0425","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s00406-008-5006-2","article-title":"Neuropsychological impairments predict the clinical course in schizophrenia","volume":"258","author":"W\u00f6lwer","year":"2008","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"3","key":"10.1016\/j.schres.2022.09.014_bb0430","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s00228-016-2162-6","article-title":"Quantification of anticholinergic and sedative drug load with the drug burden index: a review of outcomes and methodological quality of studies","volume":"73","author":"Wouters","year":"2017","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.schres.2022.09.014_bb0435","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"A rating scale for mania: reliability, validity and sensitivity","volume":"133","author":"Young","year":"1978","journal-title":"Br. J. Psychiatry"},{"issue":"10","key":"10.1016\/j.schres.2022.09.014_bb0440","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1176\/appi.ajp.2019.18091088","article-title":"Cognitive change in schizophrenia and other psychoses in the decade following the first episode","volume":"176","author":"Zanelli","year":"2019","journal-title":"Am. J. Psychiatry"},{"issue":"2\u20133","key":"10.1016\/j.schres.2022.09.014_bb0445","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.schres.2013.08.001","article-title":"Risk of symptom recurrence with medication discontinuation in first-episode psychosis: a systematic review","volume":"152","author":"Zipursky","year":"2014","journal-title":"Schizophr. Res."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996422003565?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996422003565?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:53:12Z","timestamp":1760298792000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996422003565"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":90,"alternative-id":["S0920996422003565"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2022.09.014","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relapse of first-episode schizophrenia patients and neurocognitive impairment: The role of dopaminergic and anticholinergic burden","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2022.09.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}